Exchange: NASDAQ·Updated 04:10 PM EDT
HROW logo

HROW Harrow Health Inc

$38.54
$0.28
(0.73%)
Today
Closed $38.54
$0.00
(0.00%)
After Hours
Reported EarningsAug 10
Mkt Cap$1.43B
Vol228,881.00

About HROW

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.
36

Bearish Sentiment

How do you feel about HROW?

Advertisement|Remove ads.